bioRxivMolecular BiologyPreprint
Integrated Stress Response Triggered by Excessive Glycosylation Drives Thoracic Aortic aneurysm
Antonio Rochano-OrtiziD, Irene San Sebastián-JarabaiD, Carmen ZamoraiD, Carolina SimóiD, Virginia García‐CañasiD, Sacramento Martínez-AlbaladejoiD, María José Fernandez-Gomez, Tiago Rodrigues VelhoiD, María Jesús Ruiz-RodrígueziD, Amanda Leal-Zafra, Enrique Gabandé‐RodrígueziD, Sara Martı́nez-Martı́neziD, Andrea GualaiD, Óscar González‐LorenzoiD, Luis Miguel Blanco‐ColioiD, José Luis Martı́n-VenturaiD, Gisela Teixidó‐TuràiD, Alberto Forteza, Juan Francisco NistaliD, Juan Miguel RedondoiD, Nerea Méndez‐BarberoiD, Marı́a MittelbrunniD, Jorge OlleriD
Abstract
Thoracic aortic aneurysms and dissections (TAAD) are marked by degenerative changes in the aortic media. Marfan syndrome is the most common inherited connective tissue disorder associated with TAAD. While vascular smooth muscle cell (VSMC) metabolism is emerging as a targetable driver of aortic aneurysm, surgical interventions remain the primary strategy to prevent aortic dissection. Our research indicates that the hexosamine biosynthetic pathway (HBP), a branch of glycolysis, is upregulated in aortas from the Fbn1C1041G/+ Marfan Syndrome mouse model. Enhancing HBP activity promotes aortic dilation and accumulation glycan-rich extracellular matrix, contributing to aortic medial degeneration in wild-type mice. Mechanistically, fueling HBP activity induces VSMC dysfunction through excessive glycosylation, which activates the Integrated Stress Response (ISR). Pharmacological inhibition of HBP, along with ISR inhibition, successfully reverses aortic dilation and aortic medial degeneration in Fbn1C1041G/+ Marfan Syndrome mouse model. Additionally, Marfan Syndrome patients show elevated levels of HBP metabolites in blood plasma and serum, and heightened HBP-ISR signaling in patients with TAAD. These findings unveil a potential causative role for the HBP-ISR axis in medial degeneration in human TAAD, underscoring the need for evaluating HBP and ISR pathway as novel biomarkers and therapeutic strategies for thoracic aortic aneurysm.
- organism: mouse
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of Angiotensin II Dependent AT1a Receptor Stimulation Attenuates Thoracic Aortic Pathology in Fibrillin-1C1041G/+ Mice
J. Z. Chen, H. Sawada, … A. Daugherty·bioRxiv·Jun 1, 2020
- Fibronectin-integrin α5 signaling promotes thoracic aortic aneurysm in a mouse model of Marfan syndrome
M. Chen, C. Cavinato, … M. A. Schwartz·bioRxiv·Aug 16, 2022
- Growth Arrest of Thoracic Aortic Aneurysms in Aging Marfan Mice
Dar Weiss, Colin Means, … Jay D. Humphrey·bioRxiv·Jun 18, 2025
- Pharmacological inhibition of mitochondrial fission mitigates experimental thoracic aortic aneurysm
Anshul S. Jadli, Karina Pereira Gomes, … Vaibhav B. Patel·bioRxiv·Mar 23, 2025
- Aberrant mechanosensitive signaling underlies activation of vascular endothelial xanthine oxidoreductase that promotes aortic aneurysm formation in Marfan syndrome
H. Yagi, H. Akazawa, … I. Komuro·bioRxiv·Jan 30, 2022
- Inhibition of myeloperoxidase prevents thoracic aortic aneurysm formation in Marfan mice
D. Mehrkens, F. S. Nettersheim, … H. Winkels·bioRxiv·Nov 24, 2022